Prior Therapy with DNA Methyltransferase Inhibitors (DNMTI) Predicts for Lower Remission Rates and Worse Survival In Secondary Acute Myeloid Leukemia Patients (sAML) Receiving Remission Induction Therapy
暂无分享,去创建一个
J. Maciejewski | Y. Saunthararajah | A. Advani | M. Sekeres | M. Kalaycio | A. Fu | E. Copelan | R. Sobecks | R. Tiu | S. Mohan | Ricki Englehaupt | M. Earl | M. Afable | Katarina Paulic